Skip main navigation

The Future for Vaccines and Antimicrobial Resistance

Discussion on the future of vaccine development
© BSAC

In a climate of limited resources it is important to prioritise research priorities, policy focus and investment decisions on vaccines that can have the greatest impact on health.

In a recent assessment of the potential of vaccines to tackle AMR, the Wellcome Trust examined WHO priority pathogens for AMR and advised how best to ensure effective vaccines are available in the future (see figure below). In some circumstances this is likely to be achieved by simply increasing uptake of licensed, effective vaccines, such as Streptococcus pneumoniae. In the case of other bacteria it involves funding to advance research and development (R&D) of promising vaccine candidates.

vaccine health impact vs probability of R&D success Image from https://vaccinesforamr.org/read-the-report/

(Click to expand)

Please visit the WHO link provided under Additional Resources to know more about vaccine research and development.

© BSAC
This article is from the free online

The Role of Vaccines in Preventing Infectious Diseases and Antimicrobial Resistance

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now